Shuttle Pharmactcls Hldgs Inc.
13F holders, Q4 2024 (December 31)6holders +2
3new positions
1sold out
$0.86avg. 13F price*
At the end of Q4 2024, 6 institutions reported holding Shuttle Pharmactcls Hldgs Inc. in their 13F filings, up 2 from Q3 2024. 3 opened new positions and 1 sold out. The largest holders were Armistice Capital, LLC ($263K), UBS Group AG ($28K) and Geode Capital Management, LLC ($9K).
- Company
- Shuttle Pharmactcls Hldgs Inc.
- CUSIP
- 825693302
- Latest filing quarter
- Q3 2025
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $300K |
| Exits | 1 | $34K |
All 13F filers, Q3 2024 → Q4 2024: 352,730 shares bought and 25,866 shares sold, net +326,864 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 6 holders
| Armistice Capital, LLC | 0.01% | New | 306,057 | $263K |
| UBS Group AG | 0.00% | New | 32,787 | $28K |
| Geode Capital Management, LLC | 0.00% | New | 10,867 | $9K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +77.9% | 6,863 | $6K |
| Federation des caisses Desjardins du Quebec | 0.00% | No change | 63 | $54 |
| Bank of America Corp. | 0.00% | Add +155.6% | 23 | $20 |
"% of holder's portfolio" is SHUTTLE PHARMACTCLS HLDGS IN's weight in each manager's 13F, not the share of Shuttle Pharmactcls Hldgs Inc. the manager owns.